3SBio: ShortMACD Bearish divergence
Stop loss: 6.40
Take profit: 5.75
R/R: 3
*No.1 Manage your Risk*
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.12 EUR
281.72 M EUR
1.23 B EUR
1.71 B
About 3SBIO INC
Sector
Industry
CEO
Jing Lou
Website
Headquarters
Shenyang
Founded
1993
FIGI
BBG009CK4G84
3SBio, Inc. operates as an investment holding company, which engages in the development, production, marketing, and sale of biopharmaceutical products. Its products are used in the field of medicine, particularly in nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. It operates through the Mainland China and Others geographical segments. The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.
Protecting the Grey Rhinos .......Read about this biopharm company here
China is in a catch 22 position now - on one hand , the government is pumping in money to support the High Tech industries like Ecommerce, automation, Electric Vehicles, RFID, Robotics, AI, etc and on the other hand, they know that they are faced with an agin
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of 83B is 1.42 EUR — it has increased by 3.76% in the past 24 hours. Watch 3SBIO INC. DL -,00001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange 3SBIO INC. DL -,00001 stocks are traded under the ticker 83B.
83B stock has fallen by −1.43% compared to the previous week, the month change is a 18.97% rise, over the last year 3SBIO INC. DL -,00001 has showed a 123.62% increase.
We've gathered analysts' opinions on 3SBIO INC. DL -,00001 future price: according to them, 83B price has a max estimate of 2.03 EUR and a min estimate of 0.97 EUR. Watch 83B chart and read a more detailed 3SBIO INC. DL -,00001 stock forecast: see what analysts think of 3SBIO INC. DL -,00001 and suggest that you do with its stocks.
83B stock is 2.86% volatile and has beta coefficient of 0.80. Track 3SBIO INC. DL -,00001 stock price on the chart and check out the list of the most volatile stocks — is 3SBIO INC. DL -,00001 there?
Today 3SBIO INC. DL -,00001 has the market capitalization of 3.32 B, it has increased by 7.46% over the last week.
Yes, you can track 3SBIO INC. DL -,00001 financials in yearly and quarterly reports right on TradingView.
3SBIO INC. DL -,00001 is going to release the next earnings report on Aug 20, 2025. Keep track of upcoming events with our Earnings Calendar.
83B earnings for the last half-year are 0.055 EUR per share, whereas the estimation was 0.057 EUR, resulting in a −3.49% surprise. The estimated earnings for the next half-year are 0.063 EUR per share. See more details about 3SBIO INC. DL -,00001 earnings.
3SBIO INC. DL -,00001 revenue for the last half-year amounts to 624.26 M EUR, despite the estimated figure of 604.45 M EUR. In the next half-year revenue is expected to reach 566.90 M EUR.
83B net income for the last half-year is 134.90 M EUR, while the previous report showed 141.17 M EUR of net income which accounts for −4.45% change. Track more 3SBIO INC. DL -,00001 financial stats to get the full picture.
3SBIO INC. DL -,00001 dividend yield was 4.11% in 2024, and payout ratio reached 26.73%. The year before the numbers were 3.32% and 35.62% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 23, 2025, the company has 5.58 K employees. See our rating of the largest employees — is 3SBIO INC. DL -,00001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 3SBIO INC. DL -,00001 EBITDA is 412.17 M EUR, and current EBITDA margin is 33.58%. See more stats in 3SBIO INC. DL -,00001 financial statements.
Like other stocks, 83B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 3SBIO INC. DL -,00001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 3SBIO INC. DL -,00001 technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 3SBIO INC. DL -,00001 stock shows the strong buy signal. See more of 3SBIO INC. DL -,00001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.